Acurx Pharmaceuticals (ACXP)
(Delayed Data from NSDQ)
$5.05 USD
-0.04 (-0.80%)
Updated Aug 6, 2025 03:59 PM ET
After-Market: $5.21 +0.16 (3.18%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Acurx Pharmaceuticals, Inc. has a market cap of $7.83M, which represents its share price of $5.09 multiplied by its outstanding shares number of 1.54M. As a small-cap company, ACXP's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ACXP 5.05 -0.04(-0.80%)
Will ACXP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACXP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACXP
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year?
Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
ACXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Other News for ACXP
ACXP Trading Halted as Acurx Pharmaceuticals Awaits News
Acurx Pharmaceuticals trading halted, news pending
Acurx (ACXP) Implements 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing
Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split | ACXP Stock News
Acurx approves 1-for-20 reverse stock split